Patients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy
P. V. Morinets,
А. S. Navasardyan,
Е. А. Strebkova,
P. Е. Коmarov,
S. I. Popova,
O. V. Ushakova,
E. A. Morozova https://doi.org/10.20340/vmirvz.2021.2.COVID.1
Abstract
New coronavirus infection (COVID-19) – a serious medical and social problem. Despite the achievement of certain successes in the treatment of patients with COVID-19, there is a need to develop special clinical and organizational approaches in patients with CKD who are on renal replacement therapy and are at special risk due to the course of the underlying disease and concomitant pathology. The article presents the experience of the Samara Regional Center of Nephrology and Dialysis of the Samara Regional Clinical Hospital named after V.D. Seredavin during the pandemic, as well as the features of the management of patients with stage 5 chronic kidney disease undergoing renal replacement therapy in the infectious department to provide MP to patients with COVID-19. Patients with CKD require increased attention, treatment of coronavirus infection (both specific and concomitant) should be carried out in full, while observing the regimens and dosage regimens of drugs and their combinations.
About the Authors
P. V. Morinets
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
А. S. Navasardyan
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
Е. А. Strebkova
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
P. Е. Коmarov
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
S. I. Popova
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
O. V. Ushakova
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
E. A. Morozova
Samara Regional Clinical Hospital named after V.D. Seredavin
Russian Federation
Russian Federation
Samara
References
1. Shen Q, Wang M, Che R et al. Chinese Society of Pediatric Nephrology and Chinese Medical Doctor Association of Pediatric Nephrology. Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol. 2020 Jul;35(7):1351-1357. https://doi.org/10.1007/s00467-020-04555-x. Epub 2020 Apr 24. PMID: 32333285; PMCID: PMC7181108.
2. Kliger AS, Silberzweig J. Mitigating Risk of COVID-19 in Dialysis Facilities. Clin J Am Soc Nephrol. 2020 May 7;15(5):707-709. https://doi.org/10.2215/CJN.03340320. Epub 2020 Mar 20. PMID: 32198130; PMCID: PMC7269225.
3. Rombolà G, Brunini F. COVID-19 and dialysis: why we should be worried. J Nephrol. 2020 Jun;33(3):401-403. https://doi.org/10.1007/s40620-020-00737-w. PMID: 32323202; PMCID: PMC7175820.
4. COVID-19 Task Force Committee of the Japanese Association of Dialysis Physicians; Japanese Society for Dialysis Therapy; Japanese Society of Nephrology, Kikuchi K, Nangaku M, Ryuzaki M et al. COVID-19 of dialysis patients in Japan: Current status and guidance on preventive measures. Ther Apher Dial. 2020 Aug;24(4):361-365. https://doi.org/10.1111/1744-9987.13531. PMID: 32506762; PMCID: PMC7301044.
5. Corbett RW, Blakey S, Nitsch D et al. West London Renal and Transplant Centre. Epidemiology of COVID19 in an Urban Dialysis Center. J Am Soc Nephrol. 2020 Aug;31(8):1815-1823. https://doi.org/10.1681/ASN.2020040534. Epub 2020 Jun 19. PMID: 32561681; PMCID: PMC7460899.
6. Ikizler TA. COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do? Am J Kidney Dis. 2020 Jul;76(1):1-3. https://doi.org/10.1053/j.ajkd.2020.03.008. Epub 2020 Mar 23. PMID: 32217082; PMCID: PMC7146661.
7. Hassanein M, Radhakrishnan Y, Sedor J et al. COVID-19 and the kidney. Cleve Clin J Med. 2020 Oct 1;87(10):619-631. https://doi.org/10.3949/ccjm.87a.20072. PMID: 33004323.
Review
For citations:
Morinets P.V., Navasardyan А.S., Strebkova Е.А., Коmarov P.Е., Popova S.I., Ushakova O.V., Morozova E.A. Patients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2021;(2):5-10. (In Russ.) https://doi.org/10.20340/vmirvz.2021.2.COVID.1
Views:
1866
Email this article 